| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
|---|---|---|---|---|---|
Gross Sales | 16,270.46 | 12,069.02 | 13,764.06 | 10,128.72 | 12,758.86 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 16,270.46 | 12,069.02 | 13,764.06 | 10,128.72 | 12,758.86 |
Other Operating Income | 0 | 0 | 0 | 0 | 731.51 |
Other Income | 285.36 | 238.96 | 288.33 | 321.92 | 234.68 |
Total Income | 16,555.82 | 12,307.98 | 14,052.39 | 10,450.64 | 13,725.05 |
Total Expenditure | 15,134.54 | 11,963.37 | 12,819.66 | 10,460.52 | 12,123.79 |
PBIDT | 1,421.28 | 344.61 | 1,232.73 | -9.88 | 1,601.26 |
Interest | 385.21 | 363.12 | 382.92 | 348.37 | 300.31 |
PBDT | 1,036.07 | -18.51 | 849.81 | -358.25 | 1,300.95 |
Depreciation | 152.9 | 119.06 | 129 | 119.9 | 135.04 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 10.71 | 12.45 | -23.24 | -89.32 | 48.43 |
Deferred Tax | 233.31 | -44.77 | 194.11 | -121.11 | 287.47 |
Reported Profit After Tax | 639.15 | -105.25 | 549.94 | -267.72 | 830.01 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 639.15 | -105.25 | 549.94 | -267.72 | 830.01 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 639.15 | -105.25 | 549.94 | -267.72 | 830.01 |
EPS (Unit Curr.) | 1.84 | -0.3 | 1.58 | -0.77 | 2.38 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 696.41 | 696.41 | 696.41 | 696.41 | 696.41 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 8.73 | 2.85 | 8.95 | -0.09 | 12.55 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 3.92 | -0.87 | 3.99 | -2.64 | 6.5 |
With this historic milestone, BHEL's overall order book was at ₹1.95 lakh crore as on FY25, representing robust project acquisition in core sectors.
This technology is yet another cost-effective option for imported materials such as Zirfon and asbestos-based diaphragms.
The agreement does not include any transfer of equity of setting up a new venture, and no upfront consideration is involved.
Here are some of the stocks that may see significant price movement today: BHEL, Coromandel International, Aurobindo Pharma, etc.
This project was awarded to AESL through a tariff-based competitive bidding process.
The case highlights broader challenges for infrastructure and power sector companies involving contract execution, payment disputes and financial recoveries.
BHEL was awarded the contract following an international competitive bidding process and is expected to complete the project in 54 months.
The value of the contract is estimated at ₹231.77 crore (ex-GST).
The DCT system enables continuous communication between the ship and the shore arms, with high precision, speed, security, and reliability of critical maritime operations.
In Q3 FY25, BHEL reported a 170% YoY increase in net profit, reaching ₹124 crore, while revenue grew 32% YoY to ₹7,277 crore, reflecting strong financial performance.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
